Literature DB >> 10196309

An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.

C Helga-Maria1, M L Hammarskjöld, D Rekosh.   

Abstract

Although most reports defining the human immunodeficiency virus type 1 (HIV-1) genomic RNA packaging signal have focused on the region downstream of the major 5' splice site, others have suggested that sequences upstream of the splice site may also play an important role. In this study we have directly examined the role played by the HIV-1 TAR region in RNA packaging. For these experiments we used a proviral expression system that is largely independent of Tat for transcriptional activation. This allowed us to create constructs that efficiently expressed RNAs carrying mutations in TAR and to determine the ability of these RNAs to be packaged. Our results indicate that loss of sequences in TAR significantly reduce the ability of a viral RNA to be packaged. The requirement for TAR sequences in RNA packaging was further examined by using a series of missense mutations positioned throughout the entire TAR structure. TAR mutations previously shown to influence Tat transactivation, such as G31U in the upper loop region or UCU to AAG in the bulge (nucleotides [nt] 22 to 24), failed to have any effect on RNA packaging. Mutations which disrupted the portion of the TAR stem immediately below the bulge also had little effect. In contrast, dramatic effects on RNA packaging were observed with constructs containing mutations in the lower portion of the TAR stem. Point mutations which altered nt 5 to 9, 10 to 15, 44 to 49, or 50 to 54 all reduced RNA packaging 11- to 25-fold. However, compensatory double mutations which restored the stem structure were able to restore packaging. These results indicate that an intact lower stem structure, rather than a specific sequence, is required for RNA packaging. Our results also showed that RNA molecules retained within the nucleus cannot be packaged, unless they are transported to the cytoplasm by either Rev/Rev response element or the Mason-Pfizer monkey virus constitutive transport element.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196309      PMCID: PMC104192     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

Review 1.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

2.  Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.

Authors:  K T Jeang; D R Rawlins; P J Rosenfeld; J H Shero; T J Kelly; G S Hayward
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.

Authors:  M S McBride; A T Panganiban
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.

Authors:  J F Kaye; J H Richardson; A M Lever
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA.

Authors:  R K Ernst; M Bray; D Rekosh; M L Hammarskjöld
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

6.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.

Authors:  D Harrich; G Mavankal; A Mette-Snider; R B Gaynor
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

Authors:  J Clever; C Sassetti; T G Parslow
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.

Authors:  Y Zhang; E Barklis
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  43 in total

1.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

3.  Exciton interaction in molecular beacons: a sensitive sensor for short range modifications of the nucleic acid structure.

Authors:  S Bernacchi; Y Mély
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

5.  In vitro characterization of a base pairing interaction between the primer binding site and the minimal packaging signal of avian leukosis virus genomic RNA.

Authors:  Igor Kanevsky; Natalya Vasilenko; Hélène Dumay-Odelot; Philippe Fossé
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

6.  Nuclear RNA export and packaging functions of HIV-1 Rev revisited.

Authors:  Maik Blissenbach; Bastian Grewe; Bianca Hoffmann; Sabine Brandt; Klaus Uberla
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

8.  The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.

Authors:  D Harrich; C W Hooker; E Parry
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

10.  The C-terminal p6 domain of the HIV-1 Pr55Gag precursor is required for specific binding to the genomic RNA.

Authors:  Noé Dubois; Keith K Khoo; Shannon Ghossein; Tanja Seissler; Philippe Wolff; William J McKinstry; Johnson Mak; Jean-Christophe Paillart; Roland Marquet; Serena Bernacchi
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.